Stroke and cerebrovascular diseases in patients with chronic kidney disease

The Lancet Neurology

Volumn 13, Issue 8, 2014, Pages 823-833

  Toyoda, Kazunori ^a   Ninomiya, Toshiharu ^b  

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT THERAPY; BRAIN HEMORRHAGE; BRAIN INFARCTION; CARDIOVASCULAR RISK; CAROTID ARTERY; CAROTID ENDARTERECTOMY; CEREBROVASCULAR ACCIDENT; CEREBROVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; COGNITION; COGNITIVE DEFECT; DEMENTIA; DISEASE ASSOCIATION; END STAGE RENAL DISEASE; ENDOTHELIAL DYSFUNCTION; ENDOVASCULAR SURGERY; FIBRINOLYTIC THERAPY; HUMAN; MEDLINE; NEUROPROTECTION; PHARMACEUTICAL CARE; PRIORITY JOURNAL; RENOVASCULAR DISEASE; REVIEW; RISK ASSESSMENT; STROKE PATIENT; WHITE MATTER; DISEASE SEVERITY; HIGH RISK PATIENT; META ANALYSIS (TOPIC); MULTICENTER STUDY (TOPIC);

CEREBROVASCULAR DISORDERS; GLOMERULAR FILTRATION RATE; HUMANS; HYPERTENSION; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS; STROKE;

ALTEPLASE; CANDESARTAN HEXETIL; NICARDIPINE; WARFARIN;

EID: 84904245034     PISSN: 14744422     EISSN: 14744465     Source Type: Journal    
DOI: 10.1016/S1474-4422(14)70026-2     Document Type: Review

References (123)

1. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002, 39(suppl 1):S1-266. National Kidney Foundation.
2. Jha V, Garcia-Garcia G, Iseki K, et al. Chronic kidney disease: global dimension and perspectives. Lancet 2013, 382:260-272.
3. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004, 351:1296-1305.
4. Toyoda K The cerebro-renal interaction in stroke neurology. Neurology 2012, 78:1898-1899.
5. Toyoda K Cerebrorenal interaction and stroke. Contrib Nephrol 2013, 179:1-6.
6. Hart RG, Eikelboom JW, Ingram AJ, Herzog CA Anticoagulants in atrial fibrillation patients with chronic kidney disease. Nat Rev Nephrol 2012, 8:569-578.
7. Coresh J, Selvin E, Stevens LA, et al. Prevalence of chronic kidney disease in the United States. JAMA 2007, 298:2038-2047.
8. Hallan SI, Coresh J, Astor BC, et al. International comparison of the relationship of chronic kidney disease prevalence and ESRD risk. J Am Soc Nephrol 2006, 17:2275-2284.
9. Imai E, Horio M, Watanabe T, et al. Prevalence of chronic kidney disease in the Japanese general population. Clin Exp Nephrol 2009, 13:621-630.
10. Yahalom G, Schwartz R, Schwammenthal Y, et al. Chronic kidney disease and clinical outcome in patients with acute stroke. Stroke 2009, 40:1296-1303.
11. Ovbiagele B, Sanossian N, Liebeskind DS, et al. Indices of kidney dysfunction and discharge outcomes in hospitalized stroke patients without known renal disease. Cerebrovasc Dis 2009, 28:582-588.
12. Ovbiagele B, Bath PM, Cotton D, Sha N, Diener HC Low glomerular filtration rate, recurrent stroke risk, and effect of renin-angiotensin system modulation. Stroke 2013, 44:3223-3225. the PRoFESS Investigators.
13. Naganuma M, Koga M, Shiokawa Y, et al. Reduced estimated glomerular filtration rate is associated with stroke outcome after intravenous rt-PA: the Stroke Acute Management with Urgent Risk-Factor Assessment and Improvement (SAMURAI) rt-PA registry. Cerebrovasc Dis 2011, 31:123-129.
14. Kumai Y, Kamouchi M, Hata J, et al. Proteinuria and clinical outcomes after ischemic stroke. Neurology 2012, 78:1909-1915. the FSR Investigators.
15. Molshatzki N, Orion D, Tsabari R, et al. Chronic kidney disease in patients with acute intracerebral hemorrhage: association with large hematoma volume and poor outcome. Cerebrovasc Dis 2011, 31:271-277.
16. Miyagi T, Koga M, Yamagami H, et al. Reduced estimated glomerular filtration rate and outcomes of intracerebral hemorrhage: the SAMURAI-ICH study. Stroke 2013, 44. ATP308 (abstr).
17. Culleton BF, Larson MG, Wilson PW, Evans JC, Parfrey PS, Levy D Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency. Kidney Int 1999, 56:2214-2219.
18. Garg AX, Clark WF, Haynes RB, House AA Moderate renal insufficiency and the risk of cardiovascular mortality: results from the NHANES I. Kidney Int 2002, 61:1486-1494.
19. Weiner DE, Tighiouart H, Amin MG, et al. Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies. J Am Soc Nephrol 2004, 15:1307-1315.
20. Ninomiya T, Kiyohara Y, Tokuda Y, et al. Impact of kidney disease and blood pressure on the development of cardiovascular disease: an overview from the Japan Arteriosclerosis Longitudinal Study. Circulation 2008, 118:2694-2701. the Japan Arteriosclerosis Longitudinal Study Group.
21. Lee M, Saver JL, Chang KH, Liao HW, Chang SC, Ovbiagele B Low glomerular filtration rate and risk of stroke: meta-analysis. BMJ 2010, 341:c4249.
22. Ninomiya T, Perkovic V, Verdon C, et al. Proteinuria and stroke: a meta-analysis of cohort studies. Am J Kidney Dis 2009, 53:417-425.
23. Martiniuk AL, Lee CM, Lawes CM, et al. Hypertension: its prevalence and population-attributable fraction for mortality from cardiovascular disease in the Asia-Pacific region. J Hypertens 2007, 25:73-79. for the Asia-Pacific Cohort Studies Collaboration.
24. Gutiérrez OM, Judd SE, Muntner P, et al. Racial differences in albuminuria, kidney function, and risk of stroke. Neurology 2012, 79:1686-1692.
25. Ninomiya T Risk of stroke in kidney disease. Contrib Nephrol 2013, 179:58-66.
26. Sarnak MJ, Levey AS, Schoolwerth AC, et al. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation 2003, 108:2154-2169. the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure ResearchHigh Blood Pressure Research, Clinical CardiologyClinical Cardiology, Epidemiology and PreventionEpidemiology and Prevention.
27. Schlaich MP Sympathetic activation in chronic kidney disease: out of the shadow. Hypertension 2011, 57:683-685.
28. Gansevoort RT, Correa-Rotter R, Hemmelgarn BR, et al. Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention. Lancet 2013, 382:339-352.
29. Bugnicourt JM, Godefroy O, Chillon JM, Choukroun G, Massy ZA Cognitive disorders and dementia in CKD: the neglected kidney-brain axis. J Am Soc Nephrol 2013, 24:353-363.
30. Kusano E Mechanism by which chronic kidney disease causes cardiovascular disease and the measures to manage this phenomenon. Clin Exp Nephrol 2011, 15:627-633.
31. Moe SM Klotho: a master regulator of cardiovascular disease?. Circulation 2012, 125:2181-2183.
32. Mogi M, Horiuchi M Clinical interaction between brain and kidney in small-vessel disease. Cardiol Res Pract 2011, 2011:306189.
33. O'Rourke MF, Safar ME Relationship between aortic stiffening and microvascular disease in brain and kidney: cause and logic of therapy. Hypertension 2005, 46:200-204.
34. Wardlaw JM, Doubal F, Armitage P, et al. Lacunar stroke is associated with diffuse blood-brain barrier dysfunction. Ann Neurol 2009, 65:194-202.
35. Fazekas F, Kleinert R, Offenbacher H, et al. Pathologic correlates of incidental MRI white matter signal hyperintensities. Neurology 1993, 43:1683-1689.
36. Kang DH, Kanellis J, Hugo C, et al. Role of the microvascular endothelium in progressive renal disease. J Am Soc Nephrol 2002, 13:806-816.
37. Yao H, Takashima Y, Hashimoto M, Uchino A, Yuzuriha T Subclinical cerebral abnormalities in chronic kidney disease. Contrib Nephrol 2013, 179:24-34.
38. Khatri M, Wright CB, Nickolas TL, et al. Chronic kidney disease is associated with white matter hyperintensity volume: the Northern Manhattan Study (NOMAS). Stroke 2007, 38:3121-3126.
39. Ikram MA, Vernooij MW, Hofman A, Niessen WJ, van der Lugt A, Breteler MM Kidney function is related to cerebral small vessel disease. Stroke 2008, 39:55-61.
40. Seliger SL, Longstreth WT, Katz R, et al. Cystatin C and subclinical brain infarction. J Am Soc Nephrol 2005, 16:3721-3727.
41. Wada M, Nagasawa H, Iseki C, et al. Cerebral small vessel disease and chronic kidney disease (CKD): results of a cross-sectional study in community-based Japanese elderly. J Neurol Sci 2008, 272:36-42.
42. Shima H, Ishimura E, Naganuma T, et al. Decreased kidney function is a significant factor associated with silent cerebral infarction and periventricular hyperintensities. Kidney Blood Press Res 2011, 34:430-438.
43. Kobayashi S, Ikeda T, Moriya H, Ohtake T, Kumagai H Asymptomatic cerebral lacunae in patients with chronic kidney disease. Am J Kidney Dis 2004, 44:35-41.
44. Shima H, Ishimura E, Naganuma T, et al. Cerebral microbleeds in predialysis patients with chronic kidney disease. Nephrol Dial Transplant 2010, 25:1554-1559.
45. Ovbiagele B, Liebeskind DS, Pineda S, Saver JL Strong independent correlation of proteinuria with cerebral microbleeds in patients with stroke and transient ischemic attack. Arch Neurol 2010, 67:45-50.
46. Ovbiagele B, Wing JJ, Menon RS, et al. Association of chronic kidney disease with cerebral microbleeds in patients with primary intracerebral hemorrhage. Stroke 2013, 44:2409-2413.
47. Desbien AM, Chonchol M, Gnahn H, Sander D Kidney function and progression of carotid intima-media thickness in a community study. Am J Kidney Dis 2008, 51:584-593.
48. Kastarinen H, Ukkola O, Kesäniemi YA Glomerular filtration rate is related to carotid intima-media thickness in middle-aged adults. Nephrol Dial Transplant 2009, 24:2767-2772.
49. Bui AL, Katz R, Kestenbaum B, et al. Cystatin C and carotid intima-media thickness in asymptomatic adults: the Multi-Ethnic Study of Atherosclerosis (MESA). Am J Kidney Dis 2009, 53:389-398.
50. Zhang L, Zhao F, Yang Y, et al. Association between carotid artery intima-media thickness and early-stage CKD in a Chinese population. Am J Kidney Dis 2007, 49:786-792.
51. Ishizaka N, Ishizaka Y, Toda E, et al. Association between chronic kidney disease and carotid intima-media thickening in individuals with hypertension and impaired glucose metabolism. Hypertens Res 2007, 30:1035-1041.
52. Lemos MM, Jancikic AD, Sanches FM, et al. Intima-media thickness is associated with inflammation and traditional cardiovascular risk factors in non-dialysis-dependent patients with chronic kidney disease. Nephron Clin Pract 2010, 115:c189-c194.
53. Zoungas S, Ristevski S, Lightfoot P, et al. Carotid artery intima-medial thickness is increased in chronic renal failure. Clin Exp Pharmacol Physiol 2000, 27:639-641.
54. Briet M, Bozec E, Laurent S, et al. Arterial stiffness and enlargement in mild-to-moderate chronic kidney disease. Kidney Int 2006, 69:350-357.
55. Preston E, Ellis MR, Kulinskaya E, Davies AH, Brown EA Association between carotid artery intima-media thickness and cardiovascular risk factors in CKD. Am J Kidney Dis 2005, 46:856-862.
56. Zhou W, Ni Z, Yu Z, Shi B, Wang Q Brain natriuretic peptide is related to carotid plaques and predicts atherosclerosis in pre-dialysis patients with chronic kidney disease. Eur J Intern Med 2012, 23:539-544.
57. Kokubo Y Carotid atherosclerosis in kidney disease. Contrib Nephrol 2013, 179:35-41.
58. Kokubo Y, Nakamura S, Okamura T, et al. Relationship between blood pressure category and incidence of stroke and myocardial infarction in an urban Japanese population with and without chronic kidney disease: the Suita Study. Stroke 2009, 40:2674-2679.
59. Ohara T, Kokubo Y, Toyoda K, et al. Impact of chronic kidney disease on carotid atherosclerosis according to blood pressure category: the Suita study. Stroke 2013, 44:3537-3539.
60. Mancia G, De Backer G, Dominiczak A, et al. 2007 Guidelines for the Management of Arterial Hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007, 25:1105-1187. the Management of Arterial Hypertension of the European Society of Hypertension, the European Society of Cardiologythe European Society of Cardiology.
61. Prince M, Bryce R, Albanese E, Wimo A, Ribeiro W, Ferri CP The global prevalence of dementia: a systematic review and metaanalysis. Alzheimers Dement 2013, 9:63-75.
62. Koushik NS, McArthur SF, Baird AD Adult chronic kidney disease: neurocognition in chronic renal failure. Neuropsychol Rev 2010, 20:33-51.
63. Etgen T, Chonchol M, Förstl H, Sander D Chronic kidney disease and cognitive impairment: a systematic review and meta-analysis. Am J Nephrol 2012, 35:474-482.
64. Elias MF, Dore GA, Davey A Kidney disease and cognitive function. Contrib Nephrol 2013, 179:42-57.
65. Kurella Tamura M, Wadley V, Yaffe K, et al. Kidney function and cognitive impairment in US adults: the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study. Am J Kidney Dis 2008, 52:227-234.
66. Kurella M, Yaffe K, Shlipak MG, Wenger NK, Chertow GM Chronic kidney disease and cognitive impairment in menopausal women. Am J Kidney Dis 2005, 45:66-76.
67. Hailpern SM, Melamed ML, Cohen HW, Hostetter TH Moderate chronic kidney disease and cognitive function in adults 20 to 59 years of age: Third National Health and Nutrition Examination Survey (NHANES III). J Am Soc Nephrol 2007, 18:2205-2213.
68. Jassal SV, Roscoe J, LeBlanc D, Devins GM, Rourke S Differential impairment of psychomotor efficiency and processing speed in patients with chronic kidney disease. Int Urol Nephrol 2008, 40:849-854.
69. Elias MF, Elias PK, Seliger SL, Narsipur SS, Dore GA, Robbins MA Chronic kidney disease, creatinine and cognitive functioning. Nephrol Dial Transplant 2009, 24:2446-2452.
70. Davey A, Elias MF, Robbins MA, Seliger SL, Dore GA Decline in renal functioning is associated with longitudinal decline in global cognitive functioning, abstract reasoning and verbal memory. Nephrol Dial Transplant 2013, 28:1810-1819.
71. Helmer C, Stengel B, Metzger M, et al. Chronic kidney disease, cognitive decline, and incident dementia: the 3C Study. Neurology 2011, 77:2043-2051.
72. Murray AM, Knopman DS Cognitive impairment in CKD: no longer an occult burden. Am J Kidney Dis 2010, 56:615-618.
73. Radić J, Ljutić D, Radić M, Kovaĉić V, Sain M, Curković KD The possible impact of dialysis modality on cognitive function in chronic dialysis patients. Neth J Med 2010, 68:153-157.
74. Kuwashiro T, Sugimori H, Ago T, Kamouchi M, Kitazono T Risk factors predisposing to stroke recurrence within one year of non-cardioembolic stroke onset: the Fukuoka Stroke Registry. Cerebrovasc Dis 2012, 33:141-149. the FSR Investigators.
75. Słowik A, Turaj W, Iskra T, Strojny J, Szczudlik A Microalbuminuria in nondiabetic patients with acute ischemic stroke: prevalence, clinical correlates, and prognostic significance. Cerebrovasc Dis 2002, 14:15-21.
76. Tsagalis G, Akrivos T, Alevizaki M, et al. Renal dysfunction in acute stroke: an independent predictor of long-term all combined vascular events and overall mortality. Nephrol Dial Transplant 2009, 24:194-200.
77. Cuadrado-Godia E, Ois A, Garcia-Ramallo E, et al. Biomarkers to predict clinical progression in small vessel disease strokes: prognostic role of albuminuria and oxidized LDL cholesterol. Atherosclerosis 2011, 219:368-372.
78. Yokota C, Minematsu K, Ito A, Toyoda K, Nagasawa H, Yamaguchi T Albuminuria, but not metabolic syndrome, is a significant predictor of stroke recurrence in ischemic stroke. J Neurol Sci 2009, 277:50-53.
79. Luo Y, Wang X, Wang Y, et al. Association of glomerular filtration rate with outcomes of acute stroke in type 2 diabetic patients: results from the china national stroke registry. Diabetes Care 2014, 37:173-179. the CNSR Investigators.
80. Ng DP, Fukushima M, Tai BC, et al. Reduced GFR and albuminuria in Chinese type 2 diabetes mellitus patients are both independently associated with activation of the TNF-alpha system. Diabetologia 2008, 51:2318-2324.
81. McCarthy ET, Sharma R, Sharma M, et al. TNF-alpha increases albumin permeability of isolated rat glomeruli through the generation of superoxide. J Am Soc Nephrol 1998, 9:433-438.
82. Rodríguez-Yáñez M, Castellanos M, Blanco M, et al. Micro- and macroalbuminuria predict hemorrhagic transformation in acute ischemic stroke. Neurology 2006, 67:1172-1177.
83. Beamer NB, Coull BM, Clark WM, Wynn M Microalbuminuria in ischemic stroke. Arch Neurol 1999, 56:699-702.
84. Toyoda K, Okada Y, Jinnouchi J, et al. High blood pressure in acute ischemic stroke and underlying disorders. Cerebrovasc Dis 2006, 22:355-361.
85. Covic A, Schiller A, Mardare NG, et al. The impact of acute kidney injury on short-term survival in an Eastern European population with stroke. Nephrol Dial Transplant 2008, 23:2228-2234.
86. Tsagalis G, Akrivos T, Alevizaki M, et al. Long-term prognosis of acute kidney injury after first acute stroke. Clin J Am Soc Nephrol 2009, 4:616-622.
87. Hao Z, Wu B, Lin S, et al. Association between renal function and clinical outcome in patients with acute stroke. Eur Neurol 2010, 63:237-242.
88. Ovbiagele B, Pineda S, Saver JL Renal dysfunction and discharge destination in patients with intracerebral hemorrhage. J Stroke Cerebrovasc Dis 2011, 20:145-149.
89. Cutting S, Castro C, Lee VH, Prabhakaran S Impaired renal function is not associated with increased volume of intracerebral hemorrhage. J Stroke Cerebrovasc Dis 2014, 23:86-90.
90. Koga M, Toyoda K, Yamagami H, et al. Systolic blood pressure lowering to 160 mmHg or less using nicardipine in acute intracerebral hemorrhage: a prospective, multicenter, observational study (the Stroke Acute Management with Urgent Risk-factor Assessment and Improvement-Intracerebral Hemorrhage study). J Hypertens 2012, 30:2357-2364. the Stroke Acute Management with Urgent Risk-factor Assessment and Improvement Study Investigators.
91. Sato S, Koga M, Yamagami H, et al. Conjugate eye deviation in acute intracerebral hemorrhage: Stroke Acute Management with Urgent Risk-factor Assessment and Improvement-ICH (SAMURAI-ICH) study. Stroke 2012, 43:2898-2903.
92. Sakamoto Y, Koga M, Yamagami H, et al. Systolic blood pressure after intravenous antihypertensive treatment and clinical outcomes in hyperacute intracerebral hemorrhage: the Stroke Acute Management with Urgent Risk-factor Assessment and Improvement-Intracerebral Hemorrhage study. Stroke 2013, 44:1846-1851. the SAMURAI Study Investigators.
93. Qureshi AI, Palesch YY, Martin R, et al. Systolic blood pressure reduction and risk of acute renal injury in patients with intracerebral hemorrhage. Am J Med 2012, 125:718.
94. Jardine MJ, Ninomiya T, Perkovic V, et al. Aspirin is beneficial in hypertensive patients with chronic kidney disease: a post-hoc subgroup analysis of a randomized controlled trial. J Am Coll Cardiol 2010, 56:956-965.
95. Olesen JB, Lip GY, Kamper AL, et al. Stroke and bleeding in atrial fibrillation with chronic kidney disease. N Engl J Med 2012, 367:625-635.
96. Angiolillo DJ, Bernardo E, Capodanno D, et al. Impact of chronic kidney disease on platelet function profiles in diabetes mellitus patients with coronary artery disease taking dual antiplatelet therapy. J Am Coll Cardiol 2010, 55:1139-1146.
97. Lai HM, Aronow WS, Kalen P, et al. Incidence of thromboembolic stroke and of major bleeding in patients with atrial fibrillation and chronic kidney disease treated with and without warfarin. Int J Nephrol Renovasc Dis 2009, 2:33-37.
98. Yang F, Chou D, Schweitzer P, Hanon S Warfarin in haemodialysis patients with atrial fibrillation: what benefit?. Europace 2010, 12:1666-1672.
99. Chan KE, Lazarus JM, Thadhani R, Hakim RM Anticoagulant and antiplatelet usage associates with mortality among hemodialysis patients. J Am Soc Nephrol 2009, 20:872-881.
100. Hirano T Thrombolysis and hyperacute reperfusion therapy for stroke in renal patients. Contrib Nephrol 2013, 179:110-118.
101. Hishida A Clinical analysis of 207 patients who developed renal disorders during or after treatment with edaravone reported during post-marketing surveillance. Clin Exp Nephrol 2007, 11:292-296.
102. Protack CD, Bakken AM, Saad WE, Davies MG Influence of chronic renal insufficiency on outcomes following carotid revascularization. Arch Surg 2011, 146:1135-1141.
103. Sidawy AN, Aidinian G, Johnson ON, White PW, DeZee KJ, Henderson WG Effect of chronic renal insufficiency on outcomes of carotid endarterectomy. J Vasc Surg 2008, 48:1423-1430.
104. van Lammeren GW, Moll FL, Blankestijn PJ, et al. Decreased kidney function: an unrecognized and often untreated risk factor for secondary cardiovascular events after carotid surgery. Stroke 2011, 42:307-312.
105. Kamouchi M, Kumagai N, Okada Y, Origasa H, Yamaguchi T, Kitazono T Risk score for predicting recurrence in patients with ischemic stroke: the Fukuoka stroke risk score for Japanese. Cerebrovasc Dis 2012, 34:351-357.
106. Lip GY, Andreotti F, Fauchier L, et al. Bleeding risk assessment and management in atrial fibrillation patients. Executive Summary of a Position Document from the European Heart Rhythm Association [EHRA], endorsed by the European Society of Cardiology [ESC] Working Group on Thrombosis. Thromb Haemost 2011, 106:997-1011. the European Heart Rhythm Association.
107. Martin U, Sponer G, Strein K Influence of hepatic and renal failure on pharmacokinetic properties of the novel recombinant plasminogen activator BM 06.022 in rats. Drug Metab Dispos 1993, 21:236-241.
108. Lyrer PA, Fluri F, Gisler D, Papa S, Hatz F, Engelter ST Renal function and outcome among stroke patients treated with IV thrombolysis. Neurology 2008, 71:1548-1550.
109. Agrawal V, Rai B, Fellows J, McCullough PA In-hospital outcomes with thrombolytic therapy in patients with renal dysfunction presenting with acute ischaemic stroke. Nephrol Dial Transplant 2010, 25:1150-1157.
110. Aronow WS Acute and chronic management of atrial fibrillation in patients with late-stage CKD. Am J Kidney Dis 2009, 53:701-710.
111. Gage BF, Yan Y, Milligan PE, et al. Clinical classification schemes for predicting hemorrhage: results from the National Registry of Atrial Fibrillation (NRAF). Am Heart J 2006, 151:713-719.
112. Pisters R, Lane DA, Nieuwlaat R, de Vos CB, Crijns HJ, Lip GY A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey. Chest 2010, 138:1093-1100.
113. James PA, Oparil S, Carter BL, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA 2014, 311:507-520.
114. Merkin SS, Diez Roux AV, Coresh J, Fried LF, Jackson SA, Powe NR Individual and neighborhood socioeconomic status and progressive chronic kidney disease in an elderly population: The Cardiovascular Health Study. Soc Sci Med 2007, 65:809-821.
115. Toyoda K, Fujii K, Fujimi S, et al. Stroke in patients on maintenance hemodialysis: a 22-year single-center study. Am J Kidney Dis 2005, 45:1058-1066.
116. Toyoda K, Fujii K, Ando T, Kumai Y, Ibayashi S, Iida M Incidence, etiology, and outcome of stroke in patients on continuous ambulatory peritoneal dialysis. Cerebrovasc Dis 2004, 17:98-105.
117. Seliger SL, Gillen DL, Longstreth WT, Kestenbaum B, Stehman-Breen CO Elevated risk of stroke among patients with end-stage renal disease. Kidney Int 2003, 64:603-609.
118. van der Sande FM, Hermans MM, Leunissen KM, Kooman JP Noncardiac consequences of hypertension in hemodialysis patients. Semin Dial 2004, 17:304-306.
119. Imai E, Matsuo S, Makino H, et al. Chronic Kidney Disease Japan Cohort study: baseline characteristics and factors associated with causative diseases and renal function. Clin Exp Nephrol 2010, 14:558-570.
120. Toyoda K, Kumai Y, Fujii K, Ando T, Ibayashi S Simultaneous onset of haemorrhagic and ischaemic strokes in a haemodialysis patient. J Neurol Neurosurg Psychiatry 2002, 72:673-674.
121. Iseki K Stroke feature and management in dialysis patients. Contrib Nephrol 2013, 179:100-109.
122. Naganuma M, Mori M, Nezu T, et al. Intravenous recombinant tissue plasminogen activator therapy for stroke patients receiving maintenance hemodialysis: the Stroke Acute Management with Urgent Risk-Factor Assessment and Improvement (SAMURAI) rt-PA registry. Eur Neurol 2011, 66:37-41. the SAMURAI Study Investigators.
123. Palacio S, Gonzales NR, Sangha NS, Birnbaum LA, Hart RG Thrombolysis for acute stroke in hemodialysis: international survey of expert opinion. Clin J Am Soc Nephrol 2011, 6:1089-1093.